Creating a new vaccine to prevent syphilis infections
Development of a Chimeric Syphilis Vaccine Candidate to Combat Local, Disseminated and Congenital Syphilis Infection
This study is working on a new vaccine to help protect against syphilis, a sexually transmitted infection that's becoming more common, by testing important proteins from the bacteria that cause it in animals to see if they can help the body fight off the infection.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Victoria NIH-funded |
| Lab location | 1 site (Victoria, Canada) |
| Project ID | NIH-11075298 on NIH RePORTER |
What this research studies
This research focuses on developing a vaccine candidate to combat syphilis, a sexually transmitted infection that has seen a resurgence in many countries. The approach involves identifying key proteins from the bacteria that cause syphilis, which are crucial for its ability to evade the immune system and spread in the body. By testing these proteins in animal models, the researchers aim to determine their effectiveness in providing protection against syphilis. If successful, this vaccine could significantly reduce the incidence of syphilis and its severe complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of syphilis infection, including sexually active adults and pregnant women.
Not a fit: Patients who are already infected with syphilis or those who have contraindications to vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to an effective vaccine that prevents syphilis infections and reduces associated health complications.
How similar studies have performed: Previous research has shown promise in developing vaccines targeting similar bacterial infections, indicating potential for success in this novel approach.
Where this research is happening
Victoria, Canada
- University of Victoria — Victoria, Canada (Active)
Researchers
- Principal investigator: Cameron, Caroline E — University of Victoria
- Study coordinator: Cameron, Caroline E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.